Patient Name : Mr.

BALA KUMARAN Collected : 04/Mar/2025 09:39AM

Age/Gender : 34 Y 1 M 20 D /M Received : 04/Mar/2025 06:28PM
UHID/MR No : AHC1.0000165454 Reported : 05/Mar/2025 07:07AM
Visit ID : DCTTOPV3903 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Center location : CR Park,South Delhi

DEPARTMENT OF BIOCHEMISTRY

Test Name Result Unit Bio. Ref. Interval Method

HBA1C (GLYCATED HEMOGLOBIN) , WHOLE BLOOD EDTA
HBA1C, GLYCATED HEMOGLOBIN 8 % HPLC
ESTIMATED AVERAGE GLUCOSE 183 mg/dL Calculated
(eAG)
Comment:
Reference Range as per American Diabetes Association (ADA) 2023 Guidelines:
REFERENCE GROUP HBA1C %
NON DIABETIC <5.7
PREDIABETES 5.7 – 6.4
DIABETES ≥ 6.5
DIABETICS
EXCELLENT CONTROL 6–7
FAIR TO GOOD CONTROL 7–8
UNSATISFACTORY CONTROL 8 – 10
POOR CONTROL >10
Note: Dietary preparation or fasting is not required.
1. HbA1C is recommended by American Diabetes Association for Diagnosing Diabetes and monitoring Glycemic
Control by American Diabetes Association guidelines 2023.
2. Trends in HbA1C values is a better indicator of Glycemic control than a single test.
3. Low HbA1C in Non-Diabetic patients are associated with Anemia (Iron Deficiency/Hemolytic), Liver Disorders, Chronic Kidney Disease. Clinical Correlation is
advised in interpretation of low Values.
4. Falsely low HbA1c (below 4%) may be observed in patients with clinical conditions that shorten erythrocyte life span or decrease mean erythrocyte age. HbA1c may
not accurately reflect glycemic control when clinical conditions that affect erythrocyte survival are present.
5. In cases of Interference of Hemoglobin variants in HbA1C, alternative methods (Fructosamine) estimation is recommended for Glycemic Control
A: HbF >25%
B: Homozygous Hemoglobinopathy.
(Hb Electrophoresis is recommended method for detection of Hemoglobinopathy)

Page 1 of 5

SIN No:BI24544879
Patient Name : Mr.BALA KUMARAN Collected : 04/Mar/2025 09:39AM
Age/Gender : 34 Y 1 M 20 D /M Received : 04/Mar/2025 02:31PM
UHID/MR No : AHC1.0000165454 Reported : 04/Mar/2025 03:42PM
Visit ID : DCTTOPV3903 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Center location : CR Park,South Delhi

DEPARTMENT OF BIOCHEMISTRY

Test Name Result Unit Bio. Ref. Interval Method

LIPID PROFILE , SERUM
TOTAL CHOLESTEROL 114 mg/dL <200 CHE/CHO/POD
TRIGLYCERIDES 165 mg/dL <150 Enzymatic
HDL CHOLESTEROL 27 mg/dL >40 CHE/CHO/POD
NON-HDL CHOLESTEROL 87 mg/dL <130 Calculated
LDL CHOLESTEROL 54 mg/dL <100 Calculated
VLDL CHOLESTEROL 33 mg/dL <30 Calculated
CHOL / HDL RATIO 4.22 0-4.97 Calculated
ATHEROGENIC INDEX (AIP) 0.43 <0.11 Calculated

Comment:
Reference Interval as per National Cholesterol Education Program (NCEP) Adult Treatment Panel III Report.

Desirable Borderline High High Very High

TOTAL CHOLESTEROL < 200 200 - 239 ≥ 240
TRIGLYCERIDES <150 150 - 199 200 - 499 ≥ 500
Optimal < 100
LDL 130 - 159 160 - 189 ≥ 190
Near Optimal 100-129
HDL ≥ 60
Optimal <130;
NON-HDL CHOLESTEROL 160-189 190-219 >220
Above Optimal 130-159

Page 2 of 5

SIN No:BI24544877
Patient Name : Mr.BALA KUMARAN Collected : 04/Mar/2025 09:39AM
Age/Gender : 34 Y 1 M 20 D /M Received : 04/Mar/2025 06:30PM
UHID/MR No : AHC1.0000165454 Reported : 04/Mar/2025 09:24PM
Visit ID : DCTTOPV3903 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Center location : CR Park,South Delhi

DEPARTMENT OF BIOCHEMISTRY

Test Name Result Unit Bio. Ref. Interval Method

MICROALBUMIN /CREATININE RATIO - URINE , URINE
MICROALBUMIN ( MAU)- SPOT URINE 8.265 mg/dL < 1.7 Turbidimetry
CREATININE - URINE 74.4 mg/dL 20-400 Enzyme Kinetic
URINE MICROALBUMIN/CREATININE 111.09 ug/mg <30 Calculated
RATIO
Comment:
American Diabetes Association Definition of Microalbuminuria
MICROALBUMIN 24 HOUR MICROALBUMIN
CATEGORY URINE (MAU)/CREATININE RATIO
(mg/24 hour) (µg/mg of creatinine)
NORMAL < 30 < 30
MICROALBUMINURIA 30- 300 30- 300
CLINICAL ALBUMINURIA > 300 > 300

Measurement of the urine albumin-to-creatinine ratio is recommended by the American Diabetes Association to screen for
microalbuminuria.
Increased excretion of albumin (microalbuminuria) is a predictor of future development of clinical renal disease in patients with
hypertension or DM.
Microalbuminuria may be seen transiently during pregnancy, after exercise, and with protein loading, hyperglycemia, fever, and
urinary tract infections. There is also day-to-day, as well as diurnal, variation in albumin excretion. Hence, it is important to base
treatment on the results of several tests. Vigorous exercise can cause a transient increase in albumin excretion. Patients should
refrain from vigorous exercise in the 24 hours prior to the test.

Page 3 of 5

SIN No:BI24544878
Patient Name : Mr.BALA KUMARAN Collected : 04/Mar/2025 09:39AM
Age/Gender : 34 Y 1 M 20 D /M Received : 04/Mar/2025 02:31PM
UHID/MR No : AHC1.0000165454 Reported : 04/Mar/2025 03:42PM
Visit ID : DCTTOPV3903 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Center location : CR Park,South Delhi

DEPARTMENT OF BIOCHEMISTRY

Test Name Result Unit Bio. Ref. Interval Method

POTASSIUM , SERUM 4.3 mmol/L 3.5-5.1 Direct ISE

Test Name Result Unit Bio. Ref. Interval Method

SODIUM , SERUM 140 mmol/L 135-145 Direct ISE

Page 4 of 5

SIN No:BI24544877
Patient Name : Mr.BALA KUMARAN Collected : 04/Mar/2025 09:39AM
Age/Gender : 34 Y 1 M 20 D /M Received : 04/Mar/2025 02:23PM
UHID/MR No : AHC1.0000165454 Reported : 04/Mar/2025 03:41PM
Visit ID : DCTTOPV3903 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Center location : CR Park,South Delhi

DEPARTMENT OF CLINICAL PATHOLOGY

Test Name Result Unit Bio. Ref. Interval Method

COMPLETE URINE EXAMINATION (CUE) , URINE
PHYSICAL EXAMINATION
COLOUR PALE YELLOW PALE YELLOW Visual
TRANSPARENCY CLEAR CLEAR Physical Measurement
pH 5.0 5-7.5 Double Indicator
SP. GRAVITY 1.030 1.002-1.030 Bromothymol Blue
BIOCHEMICAL EXAMINATION
URINE PROTEIN NEGATIVE NEGATIVE Protein Error Of
Indicator
GLUCOSE POSITIVE (++) NEGATIVE Glucose Oxidase
URINE BILIRUBIN NEGATIVE NEGATIVE Azo Coupling Reaction
URINE KETONES (RANDOM) NEGATIVE NEGATIVE Sodium Nitro Prusside
UROBILINOGEN Normal NORMAL Modifed Ehrlich
Reaction
NITRITE NEGATIVE NEGATIVE Diazotization
LEUCOCYTE ESTERASE NEGATIVE NEGATIVE Leucocyte Esterase
CENTRIFUGED SEDIMENT WET MOUNT AND MICROSCOPY
PUS CELLS 2-4 /hpf 0-5 Microscopy
EPITHELIAL CELLS 1-2 /hpf <10 Microscopy
RBC ABSENT /hpf 0-2 Microscopy
CASTS ABSENT 0-2 Hyaline Cast Microscopy
CRYSTALS ABSENT ABSENT Microscopy

Comment:
All urine samples are checked for adequacy and suitability before examination. All abnormal chemical examination are rechecked
and verified by manual methods. Microscopy findings are reported as an average of 10 high power fields.

*** End Of Report ***

Page 5 of 5

SIN No:C03536816
 Patient Name : Mr.BALA KUMARAN Collected : 04/Mar/2025 09:39AM
Age/Gender : 34 Y 1 M 20 D /M Received : 04/Mar/2025 02:23PM
UHID/MR No : AHC1.0000165454 Reported : 04/Mar/2025 03:41PM
Visit ID : DCTTOPV3903 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Center location : CR Park,South Delhi

TERMS AND CONDITIONS GOVERNING THIS REPORT

1. Reported results are for information and interpretation of the referring doctor or such other medical professionals,
who understandreporting units, reference ranges and limitation of technologies.Laboratories not be responsible for any
interpretation whatsoever.
2. It is presumed that the tests performed are, on the specimen / sample being to the patient named or identified and the
verifications of parrticulars have been confirmed by the patient or his / her representative at the point of generation of said specimen.
3. The reported results are restricted to the given specimen only. Results may vary from lab to lab and from time to time for the same
parameter for the same patient (within subject biological variation).
4. The patient details along with their results in certain cases like notifiable diseases and as per local regulatory requirements will be
communicated to the assigned regulatory bodies.
5. The patient samples can be used as part of internal quality control, test verification, data analysis purposes within the testing scope of
the laboratory.
6. This report is not valid for medico legal purposes. It is performed to facilitate medical diagnosis only.

SIN No:C03536816
BALA KUMARAN | AHC1.0000165454

Your body system at a glance

Our clinical intelligence engine collates all of your results
to give an overall view of your health. You can track each
body system at length in this report.

Needs Needs
attention attention

Read more Blood Read more Bone &

in page 7 Glucose in page 8 Muscle

PARTIAL DATA PARTIAL DATA

Borderline Borderline

Read more Heart Read more Blood

in page 9 Health in page 11 Health

PARTIAL DATA PARTIAL DATA

Borderline Borderline

Read more Kidney Read more Vitamins

in page 14 Health in page 16

PARTIAL DATA PARTIAL DATA

SMART REPORT OVERVIEW | PAGE 1

BALA KUMARAN | AHC1.0000165454

Borderline Borderline

Read more Hormone

in page 17 Health Read more Brain &
in page 18 Nerve
PARTIAL DATA

GI & Liver Skin &

Hair

PARTIAL DATA PARTIAL DATA

SMART REPORT OVERVIEW | PAGE 2

BALA KUMARAN | AHC1.0000165454

Body systems that need attention

Here’s what you need to focus on

Blood Glucose summary

PAGE 7

2 important test's are out of range

Few parameters are showing higher

risk which include eAG, Hba1C

Bone & Muscle summary

PAGE 8

1 important test is borderline

Few parameters are showing higher

risk which include Calcium

SMART REPORT ORGAN SUMMARIES | PAGE 3

BALA KUMARAN | AHC1.0000165454

Heart Health summary

PAGE 9

3 important test's are out of range

Few parameters are showing higher

risk which include HDL, eAG

Blood Health summary

PAGE 11

1 important test is borderline

Few parameters are showing higher

risk which include Monocytes

SMART REPORT ORGAN SUMMARIES | PAGE 4

BALA KUMARAN | AHC1.0000165454

Kidney Health summary

PAGE 14

2 important test's are out of range

Few parameters are showing higher

risk which include eAG, Hba1C

Vitamins summary
PAGE 16

1 important test is borderline

Few parameters are showing higher

risk which include Calcium

SMART REPORT ORGAN SUMMARIES | PAGE 5

BALA KUMARAN | AHC1.0000165454

Hormone Health summary

PAGE 17

3 important test's are out of range

Few parameters are showing higher

risk which include eAG, HDL
Cholesterol - Serum

Brain & Nerve summary

PAGE 18

2 important test's are out of range

Few parameters are showing higher

risk which include eAG, Hba1C

SMART REPORT ORGAN SUMMARIES | PAGE 6

BALA KUMARAN | AHC1.0000165454

Blood Glucose

2 OUT OF RANGE

Estimated Average 183.00 mg/dL

Glucose (EAG)* OUT OF RANGE
4th Mar, 2025

Hba1C or Glycated 8.00 %

Hemoglobin* OUT OF RANGE
4th Mar, 2025

* Important values that determine the organ health as marked by our doctors

SMART REPORT BLOOD GLUCOSE | PAGE 7

BALA KUMARAN | AHC1.0000165454

Bone & Muscle

Calcium, Serum* 8.30 mg/dL

BORDERLINE
31st Oct, 2024

* Important values that determine the organ health as marked by our doctors

SMART REPORT BONE & MUSCLE | PAGE 8

BALA KUMARAN | AHC1.0000165454

Heart Health

3 OUT OF RANGE

Total Cholesterol - Serum* 114.00 mg/dL

IN RANGE
4th Mar, 2025

Triglycerides - Serum* 165.00 mg/dL

BORDERLINE
4th Mar, 2025

HDL Cholesterol - Serum* 27.00 mg/dL

OUT OF RANGE
4th Mar, 2025

LDL Cholesterol - Serum* 54.00 mg/dL

IN RANGE
4th Mar, 2025

Non-HDL Cholesterol* 87.00 mg/dL

IN RANGE
4th Mar, 2025

* Important values that determine the organ health as marked by our doctors

SMART REPORT HEART HEALTH | PAGE 9

BALA KUMARAN | AHC1.0000165454

Estimated Average 183.00 mg/dL

Glucose (EAG) OUT OF RANGE
4th Mar, 2025

VLDL Cholesterol - Serum 33.00 mg/dL

IN RANGE
4th Mar, 2025

Total Cholesterol / HDL 4.22

Ratio IN RANGE
4th Mar, 2025

Hba1C or Glycated 8.00 %

Hemoglobin OUT OF RANGE
4th Mar, 2025

SMART REPORT HEART HEALTH | PAGE 10

BALA KUMARAN | AHC1.0000165454

Blood Health

1 IMPROVED VALUE

Basophils* 0.80 %
IN RANGE
31st Oct, 2024

Hemoglobin* 14.60 g/dL

IN RANGE
31st Oct, 2024

Platelet Count* 189.00 10^3/ul

IN RANGE
31st Oct, 2024

MCH (Mean Corpuscular 29.80 pg

HB)* IN RANGE
31st Oct, 2024

Lymphocytes* 30.50 %
IN RANGE
31st Oct, 2024

* Important values that determine the organ health as marked by our doctors

SMART REPORT BLOOD HEALTH | PAGE 11

BALA KUMARAN | AHC1.0000165454

MCHC (Mean Corpuscular 33.90 g/dL

HB Concentration)* IN RANGE
31st Oct, 2024

4.92
Red Blood Cell Count* Million/cu.mm
31st Oct, 2024 IN RANGE

Packed Cell Volume 43.20 %

(PCV)* IN RANGE
31st Oct, 2024

Total Leucocytes Count

(WBC)* 6.01 10³/mm³
IN RANGE
31st Oct, 2024
IMPROVED

Monocytes* 8.20 %
BORDERLINE
31st Oct, 2024

* Important values that determine the organ health as marked by our doctors

SMART REPORT BLOOD HEALTH | PAGE 12

BALA KUMARAN | AHC1.0000165454

84.14
Eosinophils* Cells/cu.mm
31st Oct, 2024 IN RANGE

Mean Cell Volume (MCV)* 87.90 fL

IN RANGE
31st Oct, 2024

* Important values that determine the organ health as marked by our doctors

SMART REPORT BLOOD HEALTH | PAGE 13

BALA KUMARAN | AHC1.0000165454

Kidney Health

2 OUT OF RANGE

Potassium - Serum* 4.30 mmol/L

IN RANGE
4th Mar, 2025

Creatinine* 0.70 mg/dL

BORDERLINE
31st Oct, 2024

Blood Urea Nitrogen* 11.30 mg/dL

IN RANGE
31st Oct, 2024

Urea* 24.20 mg/dL

BORDERLINE
31st Oct, 2024

Calcium, Serum* 8.30 mg/dL

BORDERLINE
31st Oct, 2024

* Important values that determine the organ health as marked by our doctors

SMART REPORT KIDNEY HEALTH | PAGE 14

BALA KUMARAN | AHC1.0000165454

Specific Gravity 1.03

BORDERLINE
4th Mar, 2025

Estimated Average 183.00 mg/dL

Glucose (EAG) OUT OF RANGE
4th Mar, 2025

pH-value 5.0
IN RANGE
4th Mar, 2025

Hba1C or Glycated 8.00 %

Hemoglobin OUT OF RANGE
4th Mar, 2025

Phosphorus, Inorganic - 4.70 mg/dL

Serum BORDERLINE
31st Oct, 2024

Chloride - Serum 97.00 mmol/L

BORDERLINE
31st Oct, 2024

SMART REPORT KIDNEY HEALTH | PAGE 15

BALA KUMARAN | AHC1.0000165454

Vitamins

Calcium, Serum 8.30 mg/dL

BORDERLINE
31st Oct, 2024

* Important values that determine the organ health as marked by our doctors

SMART REPORT VITAMINS | PAGE 16

BALA KUMARAN | AHC1.0000165454

Hormone Health

3 OUT OF RANGE

Estimated Average 183.00 mg/dL

Glucose (EAG) OUT OF RANGE
4th Mar, 2025

HDL Cholesterol - Serum 27.00 mg/dL

OUT OF RANGE
4th Mar, 2025

Hba1C or Glycated 8.00 %

Hemoglobin OUT OF RANGE
4th Mar, 2025

* Important values that determine the organ health as marked by our doctors

SMART REPORT HORMONE HEALTH | PAGE 17

BALA KUMARAN | AHC1.0000165454

Brain & Nerve

2 OUT OF RANGE

Estimated Average 183.00 mg/dL

Glucose (EAG) OUT OF RANGE
4th Mar, 2025

Hba1C or Glycated 8.00 %

Hemoglobin OUT OF RANGE
4th Mar, 2025

* Important values that determine the organ health as marked by our doctors

SMART REPORT BRAIN & NERVE | PAGE 18

BALA KUMARAN | AHC1.0000165454

GI & Liver

Urobilinogen Normal
4th Mar, 2025 IN RANGE

* Important values that determine the organ health as marked by our doctors

SMART REPORT GI & LIVER | PAGE 19

BALA KUMARAN | AHC1.0000165454

Skin & Hair

1 IMPROVED VALUE

Total Leucocytes Count

(WBC) 6.01 10³/mm³
IN RANGE
31st Oct, 2024
IMPROVED

* Important values that determine the organ health as marked by our doctors

SMART REPORT SKIN & HAIR | PAGE 20

BALA KUMARAN | AHC1.0000165454

Creatinine * 0.70 mg/dL

31st Oct, 2024 BORDERLINE

• Creatinine is a waste product from muscle

breakdown, filtered by the kidneys. This test helps
assess kidney function, as high levels may
indicate impaired kidney filtration.
• High levels may indicate kidney dysfunction, while
normal levels show proper kidney filtration.
YOUR VALUE

0.70 mg/dL

Ideal range (0.7-1.2)

* Important values that determine the organ health as marked by our doctors

SMART REPORT PARAMETER IN FOCUS | PAGE 21

BALA KUMARAN | AHC1.0000165454

Hba1C 8.00 %
4th Mar, 2025 OUT OF RANGE

• HbA1C measures the percentage of sugar

attached to hemoglobin in red blood cells. It
reflects average blood sugar levels over 2-3
months and helps diagnose and monitor diabetes.
• High HbA1c levels indicate prolonged high blood
sugar, which can damage brain blood vessels,
increase stroke risk, and contribute to cognitive
decline and dementia.
PAST RESULTS

IN RANGE BORDERLINE OUT OF RANGE

SMART REPORT PARAMETER IN FOCUS | PAGE 22

BALA KUMARAN | AHC1.0000165454

Specific Gravity 1.03

4th Mar, 2025 BORDERLINE

• Specific gravity measures urine concentration. It

helps assess kidney function and hydration status.
Higher values indicate dehydration, while lower
values suggest overhydration.
• High values indicate dehydration, while low values
may suggest overhydration or kidney issues.
PAST RESULTS

IN RANGE BORDERLINE OUT OF RANGE

SMART REPORT PARAMETER IN FOCUS | PAGE 23

BALA KUMARAN | AHC1.0000165454

HDL 27.00 mg/dL

4th Mar, 2025 OUT OF RANGE

• HDL ("good" cholesterol) helps remove excess fat

from the blood, protecting heart health. This test
measures HDL levels to assess cardiovascular
disease risk.
• Supports hormone production, especially sex
hormones like estrogen and testosterone. Low
HDL may disrupt hormone balance.
PAST RESULTS

IN RANGE BORDERLINE OUT OF RANGE

SMART REPORT PARAMETER IN FOCUS | PAGE 24

BALA KUMARAN | AHC1.0000165454

Monocytes * 8.20 %
31st Oct, 2024 BORDERLINE

• This test checks monocytes, a type of white blood

cell that cleans up damaged cells and fights
germs.
• High levels mean your body might be dealing with
a long-lasting infection or inflammation.
PAST RESULTS

IN RANGE BORDERLINE OUT OF RANGE

* Important values that determine the organ health as marked by our doctors

SMART REPORT PARAMETER IN FOCUS | PAGE 25

BALA KUMARAN | AHC1.0000165454

eAG 183.00 mg/dL

4th Mar, 2025 OUT OF RANGE

• This test converts your HbA1C result into an

average blood sugar level over the past 2-3
months, helping you understand long-term
glucose trends.
• High EAG means persistent high blood sugar,
which can harm brain blood vessels, increasing
the risk of stroke and memory problems.
PAST RESULTS

IN RANGE BORDERLINE OUT OF RANGE

SMART REPORT PARAMETER IN FOCUS | PAGE 26

BALA KUMARAN | AHC1.0000165454

Urea * 24.20 mg/dL

31st Oct, 2024 BORDERLINE

• Urea is a waste product produced by the liver and

excreted by the kidneys. This test helps assess
kidney function and overall health.
• High levels may indicate kidney disease or
dehydration, while low levels may suggest liver
issues or malnutrition.
YOUR VALUE

24.20 mg/dL

Ideal range (6-24)

* Important values that determine the organ health as marked by our doctors

SMART REPORT PARAMETER IN FOCUS | PAGE 27

BALA KUMARAN | AHC1.0000165454

Phosphorus 4.70 mg/dL

31st Oct, 2024 BORDERLINE

• Phosphorus is essential for bone health, energy

production, and cell function. This test helps
assess kidney function and bone metabolism.
• High phosphorus may indicate kidney disease; low
phosphorus may result from malnutrition or
parathyroid dysfunction
YOUR VALUE

4.70 mg/dL

Ideal range (2.5-4.5)

SMART REPORT PARAMETER IN FOCUS | PAGE 28

BALA KUMARAN | AHC1.0000165454

Calcium 8.30 mg/dL

31st Oct, 2024 BORDERLINE

• The Calcium Serum Test checks calcium levels,

which are vital for muscle contraction, nerve
signaling, and blood clotting. It helps diagnose
bone diseases, kidney disorders, parathyroid
dysfunction, and calcium imbalances affecting
overall health.
• High calcium may indicate parathyroid or kidney
issues; low calcium may signal bone disease,
malnutrition, or vitamin D deficiency.
YOUR VALUE

8.30 mg/dL

Ideal range (8.6-10.2)

SMART REPORT PARAMETER IN FOCUS | PAGE 29

BALA KUMARAN | AHC1.0000165454

Triglycerides * 165.00 mg/dL

4th Mar, 2025 BORDERLINE

• This test measures the levels of triglycerides, a

type of fat in the blood. High levels may increase
the risk of heart disease.
• High triglycerides increase heart disease risk,
while low levels suggest a healthier lipid profile.
PAST RESULTS

IN RANGE BORDERLINE OUT OF RANGE

* Important values that determine the organ health as marked by our doctors

SMART REPORT PARAMETER IN FOCUS | PAGE 30